News

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
The $560 million company will stop selling products at Woolworths and Priceline and concentrate on selling weight-loss drugs ...
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
The pharmaceutical firm Novo Nordisk is pursuing a multipronged strategy to regain market share that it has lost to Eli Lilly ...
A decision is expected in the fourth quarter of 2025.
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...
Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...
Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.